Budhaditya Mukherjee
@budhaditya.bsky.social
Assistant Professor, IIT kharagpur
Reposted by Budhaditya Mukherjee
Are authors fairly judged by assessing the #journals in which their work is published? @bihutchins.bsky.social &co reveal that most influential papers are published in lower tier journals, and more authors would be better recognized with #ArticleLevelMetrics #ALMs @plosbiology.org 🧪 plos.io/4oV58Ed
December 17, 2025 at 1:55 PM
Are authors fairly judged by assessing the #journals in which their work is published? @bihutchins.bsky.social &co reveal that most influential papers are published in lower tier journals, and more authors would be better recognized with #ArticleLevelMetrics #ALMs @plosbiology.org 🧪 plos.io/4oV58Ed
Thank you so much. Honoured and humbled!!
Twelve scientists from Chile, India, Nigeria, Singapore and Taiwan have been selected as new EMBO Global Investigators – Congratulations to the new cohort! 🧪
Read the press release:
https://www.embo.org/press-releases/twelve-scientists-become-embo-global-investigators/
#funding #training
Read the press release:
https://www.embo.org/press-releases/twelve-scientists-become-embo-global-investigators/
#funding #training
December 9, 2025 at 3:22 PM
Thank you so much. Honoured and humbled!!
Reposted by Budhaditya Mukherjee
Happy to share our latest work now published in @elife.bsky.social: Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani doi.org/10.7554/eLif.... Here we explain the ability of selective host lipid utilization of drug resistant clinical
Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani
doi.org
April 30, 2025 at 2:30 AM
Happy to share our latest work now published in @elife.bsky.social: Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani doi.org/10.7554/eLif.... Here we explain the ability of selective host lipid utilization of drug resistant clinical
New Publication Alert!!
After 5 years of relentless ups & downs our group IDIlab @SMSTIITKGP reports in Plos Pathogens @plosplos.bsky.social
We unveil how antimony-resistant Leishmania donovani manipulates iron metabolism—fueling its survival while worsening anemia
After 5 years of relentless ups & downs our group IDIlab @SMSTIITKGP reports in Plos Pathogens @plosplos.bsky.social
We unveil how antimony-resistant Leishmania donovani manipulates iron metabolism—fueling its survival while worsening anemia
February 1, 2025 at 12:50 PM
New Publication Alert!!
After 5 years of relentless ups & downs our group IDIlab @SMSTIITKGP reports in Plos Pathogens @plosplos.bsky.social
We unveil how antimony-resistant Leishmania donovani manipulates iron metabolism—fueling its survival while worsening anemia
After 5 years of relentless ups & downs our group IDIlab @SMSTIITKGP reports in Plos Pathogens @plosplos.bsky.social
We unveil how antimony-resistant Leishmania donovani manipulates iron metabolism—fueling its survival while worsening anemia